Enteric fever, predominantly caused by Salmonella Typhi and Salmonella Paratyphi, is a systemic illness that continues to pose significant health challenges globally. This article presents a comprehensive and updated approach to the diagnosis and treatment of this disease.
Traditionally, the diagnosis of enteric fever has relied heavily on blood culture which, despite being the gold standard, has a sensitivity of only 40-60%. Recent advancements in molecular diagnostics, such as Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS), have shown promise in improving diagnostic accuracy. These techniques can detect bacterial DNA directly from patient samples, thereby increasing sensitivity and specificity. Serology tests, such as the Widal test, though less reliable, may be used in resource-limited settings.
Antibiotic therapy remains the mainstay of treatment for enteric fever. However, the emergence of multi-drug resistant strains necessitates careful antibiotic selection. Current guidelines recommend third-generation cephalosporins, such as ceftriaxone or cefixime, or fluoroquinolones, like ciprofloxacin, for initial empirical therapy. In cases of confirmed multi-drug resistance, azithromycin has shown efficacy. It is crucial to adjust therapy based on culture and sensitivity results to prevent treatment failure and further resistance.
Prevention strategies include improved sanitation, safe food and water practices, and vaccination. Two vaccines, Ty21a (oral) and Vi polysaccharide (injectable), are available and recommended for high-risk populations and travelers to endemic areas. However, vaccination should not replace basic hygiene practices as it provides only moderate protection.
Enteric fever remains a significant health burden, particularly in low-resource settings. While diagnostic and treatment strategies continue to evolve, emphasis should be placed on prevention and control measures to reduce the incidence of this disease. Healthcare professionals should stay abreast of current guidelines and advances to provide optimal patient care.
1.
Pancreatic cancer patients who were prescribed lorazepam for anxiety had poorer survival rates.
2.
According to a study, patients with ovarian cancer who undergo aggressive surgery have a 70% lower chance of dying.
3.
When Healthcare Chatbots Fall Short of Human Connection
4.
Even a few mutated cells can significantly impact how blood cancers develop, study finds
5.
Recently released national data on drug use and abuse among Americans.
1.
Understanding Bone Metastases: How Long Can Someone Live When Cancer Spreads To The Bones?
2.
The Ultimate Guide to Understanding Abiraterone and its Uses in Cancer Treatment
3.
Lymphomatoid Papulosis: What You Need to Know
4.
Transforming Cancer Care: Metrics, Informatics, Equity, and Real-World Evidence
5.
Bone Marrow Immune Niche Remodeling in Hematopoiesis
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Breast Cancer Awareness and Early Detection
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
4.
Common side effects of cancer treatment and how they are managed
5.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation